HUP0001464A3 - Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation - Google Patents

Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation

Info

Publication number
HUP0001464A3
HUP0001464A3 HU0001464A HUP0001464A HUP0001464A3 HU P0001464 A3 HUP0001464 A3 HU P0001464A3 HU 0001464 A HU0001464 A HU 0001464A HU P0001464 A HUP0001464 A HU P0001464A HU P0001464 A3 HUP0001464 A3 HU P0001464A3
Authority
HU
Hungary
Prior art keywords
preparation
preparing
water
active principle
highly insoluble
Prior art date
Application number
HU0001464A
Other languages
English (en)
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of HUP0001464A2 publication Critical patent/HUP0001464A2/hu
Publication of HUP0001464A3 publication Critical patent/HUP0001464A3/hu
Publication of HU225593B1 publication Critical patent/HU225593B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU0001464A 1997-02-20 1998-02-12 Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation HU225593B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI000362A IT1289938B1 (it) 1997-02-20 1997-02-20 Preparazione farmaceutica comprendente liposomi liofilizzati in cui e' incapsulato un principio attivo altamente insolubile in acqua e
PCT/EP1998/000817 WO1998036736A1 (en) 1997-02-20 1998-02-12 Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation

Publications (3)

Publication Number Publication Date
HUP0001464A2 HUP0001464A2 (hu) 2000-10-28
HUP0001464A3 true HUP0001464A3 (en) 2001-12-28
HU225593B1 HU225593B1 (en) 2007-05-02

Family

ID=11376097

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001464A HU225593B1 (en) 1997-02-20 1998-02-12 Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation

Country Status (26)

Country Link
US (1) US6319517B1 (hu)
EP (1) EP0981332B1 (hu)
JP (1) JP4290767B2 (hu)
KR (1) KR100496802B1 (hu)
CN (1) CN1089581C (hu)
AR (1) AR011681A1 (hu)
AT (1) ATE285754T1 (hu)
AU (1) AU744115B2 (hu)
BG (1) BG64580B1 (hu)
CA (1) CA2288958C (hu)
CZ (1) CZ295998B6 (hu)
DE (1) DE69828394T2 (hu)
EA (1) EA001637B1 (hu)
ES (1) ES2235320T3 (hu)
GE (1) GEP20022734B (hu)
HK (1) HK1026148A1 (hu)
HU (1) HU225593B1 (hu)
IL (1) IL131327A (hu)
IT (1) IT1289938B1 (hu)
PL (1) PL190628B1 (hu)
PT (1) PT981332E (hu)
SK (1) SK282931B6 (hu)
TR (1) TR199902025T2 (hu)
UA (1) UA70296A (hu)
WO (1) WO1998036736A1 (hu)
ZA (1) ZA981352B (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000079283A1 (en) * 1999-06-23 2000-12-28 Cornell Research Foundation, Inc. Dehydration/rehydration of marked liposomes on a test device
US6576460B1 (en) 1999-10-28 2003-06-10 Cornell Research Foundation, Inc. Filtration-detection device and method of use
CA2513575A1 (en) * 2003-01-17 2004-08-05 Threshold Pharmaceuticals, Inc. Treatment of benign prostatic hyperplasia using energolytic agents
CA2603084A1 (en) 2005-04-12 2006-10-19 Elan Pharma International Limited Nanoparticulate and controlled release compositions comprising cyclosporine
WO2008036979A2 (en) * 2006-09-22 2008-03-27 Guilford F Timothy Topical application of melatonin directly or in liposomes for the amelioration of itching and histamine and non-histamine related inflammatory skin changes
CN101049504B (zh) * 2007-04-05 2010-05-19 广州立恩生物科技有限公司 一种脂质体药物载体及其制备方法
US9446147B2 (en) 2011-02-24 2016-09-20 The Ohio State University Membrane stabilizing compositions and methods
CA2852777C (en) * 2011-10-21 2020-10-27 Celator Pharmaceuticals Inc. Lyophilized liposomes
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
EP2891485B1 (en) * 2012-08-31 2018-12-26 Chung-Ang University Industry Academic Cooperation Foundation Method for preparing microspheres for emboli, and method for preparing microspheres to which drug-containing carrier is bound
US10722465B1 (en) 2017-12-08 2020-07-28 Quicksilber Scientific, Inc. Transparent colloidal vitamin supplement
US11344497B1 (en) 2017-12-08 2022-05-31 Quicksilver Scientific, Inc. Mitochondrial performance enhancement nanoemulsion
KR102646145B1 (ko) 2018-05-31 2024-03-11 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 모공 축소용 조성물
CA3104445A1 (en) * 2018-06-27 2020-01-02 Breath Therapeutics Gmbh Pharmaceutical compositions in lyophilized form
MX2020014043A (es) * 2018-06-27 2021-03-09 Breath Therapeutics Gmbh Composiciones inhalables que comprenden inmunosupresores macrociclicos.
JP7079984B2 (ja) 2018-07-28 2022-06-03 エクソコバイオ インコーポレイテッド エキソソームの凍結乾燥方法
KR102163806B1 (ko) 2018-07-30 2020-10-07 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 피지분비 감소용 조성물
EA202092892A1 (ru) 2018-12-04 2021-05-27 Брес Терапьютикс Гмбх Ингаляционные композиции, содержащие макроциклические иммуносупрессанты
US11291702B1 (en) 2019-04-15 2022-04-05 Quicksilver Scientific, Inc. Liver activation nanoemulsion, solid binding composition, and toxin excretion enhancement method
CA3144861A1 (en) 2019-06-25 2020-12-30 Translatum Medicus, Inc. Processes of making 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives
CN111358955B (zh) * 2020-04-01 2023-05-02 重庆理工大学 一种用于治疗脂质代谢疾病的炎症靶向的宾达利纳米粒、制备方法及其应用
JP7508359B2 (ja) 2020-12-11 2024-07-01 株式会社東芝 脂質粒子の製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1173360A (en) * 1979-06-22 1984-08-28 Jurg Schrank Pharmaceutical preparations
FR2542749B1 (fr) * 1983-03-18 1985-07-12 Beghin Say Sa Copolymere allyloligosaccharide-acrylique salifie, procede de preparation du copolymere et application comme super-absorbant
US4857319A (en) * 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
US4963362A (en) * 1987-08-07 1990-10-16 Regents Of The University Of Minnesota Freeze-dried liposome mixture containing cyclosporin
US5683714A (en) * 1991-04-19 1997-11-04 Nexstar Pharmaceuticals, Inc. Liposomal cyclosporin pharmaceutical formulation
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
GB9320668D0 (en) * 1993-10-07 1993-11-24 Secr Defence Liposomes containing particulare materials
ATE164515T1 (de) * 1993-11-05 1998-04-15 Amgen Inc Herstellung von liposomen und verfahren zur substanzverkapselung

Also Published As

Publication number Publication date
BG103738A (en) 2000-05-31
DE69828394T2 (de) 2005-12-08
EA199900751A1 (ru) 2000-10-30
CZ295998B6 (cs) 2005-12-14
IT1289938B1 (it) 1998-10-19
DE69828394D1 (de) 2005-02-03
ZA981352B (en) 1998-08-19
EP0981332A1 (en) 2000-03-01
BG64580B1 (bg) 2005-08-31
JP4290767B2 (ja) 2009-07-08
EA001637B1 (ru) 2001-06-25
AU6496998A (en) 1998-09-09
CA2288958A1 (en) 1998-08-27
CZ292599A3 (cs) 2000-01-12
EP0981332B1 (en) 2004-12-29
ES2235320T3 (es) 2005-07-01
AR011681A1 (es) 2000-08-30
PL335207A1 (en) 2000-04-10
ATE285754T1 (de) 2005-01-15
KR100496802B1 (ko) 2005-06-22
PT981332E (pt) 2005-05-31
US6319517B1 (en) 2001-11-20
HK1026148A1 (en) 2000-12-08
GEP20022734B (en) 2002-07-25
IL131327A (en) 2004-07-25
TR199902025T2 (xx) 1999-11-22
PL190628B1 (pl) 2005-12-30
KR20000075479A (ko) 2000-12-15
SK282931B6 (sk) 2003-01-09
AU744115B2 (en) 2002-02-14
JP2001519776A (ja) 2001-10-23
UA70296C2 (uk) 2004-10-15
ITMI970362A1 (it) 1998-08-20
SK111099A3 (en) 2000-05-16
WO1998036736A1 (en) 1998-08-27
HUP0001464A2 (hu) 2000-10-28
CA2288958C (en) 2007-08-21
CN1248163A (zh) 2000-03-22
IL131327A0 (en) 2001-01-28
HU225593B1 (en) 2007-05-02
CN1089581C (zh) 2002-08-28
UA70296A (uk) 2004-10-15

Similar Documents

Publication Publication Date Title
HUP0001464A3 (en) Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation
HUP9903613A3 (en) Improvement in the taste of active pharmaceutical ingredients
EP0645136A3 (en) Pharmaceutical preparation of the type: physiologically active substance with sustained release.
HUP0200141A2 (en) Artificial peptides having surface activity, artificial surfactant comprising thereof and the use thereof in the preparation of artificial surfactant
IL127132A (en) Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
GB9609779D0 (en) Freeze dried liposome encapsulated amphiphilic drug compositions and a process for the preparation thereof
HUP0000318A3 (en) Tumor vaccine and process for the preparation thereof
HK1019606A1 (en) Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
ZA200201057B (en) Radiopharmaceutical products and their preparation procedure.
HK1040980A1 (zh) 聯苯磺酰基氨基氰、其製備方法及其作為藥物的用途
IL145733A0 (en) A polpyeptide containing an immunogenic portion of a breast protein and pharmaceutical compositions containing the same
IL149209A0 (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
ZA982073B (en) Pharmaceutical preparation
HK1049167A1 (en) Spherical telithromycin clusters, method for the producing and use thereof in the preparation of pharmaceutical forms.
HUP9700074A2 (en) Low molecular yeast active substance extract and process for preparing the same
SI0981332T1 (en) Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation
PL327224A1 (en) Ready-to-cook dish in the form of solid body, method of preparing same and system therefor
ZA200300777B (en) Process for the preparation of peptide salts, their use and pharmaceutical preparations comprising the peptide salts.
HK1047037B (zh) 含聚殼糖的蘭諾索爾(毫微溶膠)藥物製劑及其製備
ZA99168B (en) Pharmaceutical formulations and processes for their preparation.
IL136230A0 (en) An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
IL124342A (en) Antineoplastic peptides, their preparation and different uses thereof
EP0897988A4 (en) TKR1785'S PHYSIOLOGICALLY ACTIVE SUBSTANCES, THEIR PROCESS AND MICROBE
EP1089709A4 (en) ICE CREAM-LIKE PHARMACEUTICAL FORMULATION AND METHOD FOR PRODUCING THE SAME
IL135168A0 (en) Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees